Our special eBook brings together recent content exploring the manufacturing and scalability challenges shaping the future of advanced medicines. Discover why manufacturability is now the defining hurdle for cell and gene therapies, and how factors such as cost, funding pressures, and the need for specialized expertise are influencing which innovations succeed. We also dive into emerging solutions – from digital twins in CAR-T production to advances in AAV quality control and in vivo approaches that could make therapies truly “off the shelf.”

You’ll also find expert perspectives on workforce development, automation, and decentralization, alongside a roundtable examining how to make advanced therapies more accessible to patients worldwide. Finally, we explore how robotics, AI, and next-generation manufacturing platforms are poised to reduce costs, improve consistency, and unlock the full potential of these life-changing treatments.

Newsletters

Receive the latest pharmaceutical news, personalities, education, and career development – weekly to your inbox.

I have read and understand the Privacy Notice*

Subscribe